glp-1 news today cardiovascular outcomes 2025 november The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome The Role of GLP-1RA Medications

The Summary of Product Characteristics (SmPC) for these medications does not currently list blood clots as a recognised adverse effect

Molecular mechanisms underlying the impact of GLP-1RAs on cancer risk The regulation of cancer risk by GLP-1RAs involves several biological mechanisms, primarily encompassing metabolic regulation, direct anti-tumor effects, immune modulation, and epigenetic alterations

healthcare system increasingly operates as two separate systems an elite, proactive healthcare model for higher-income individuals and a reactive, fragmented system for everyone else

Eating less finally feels sustainable instead of a daily battle of willpower, because your biology is finally on your side

doi: 10.1111/j.1463-1326.2011.01420.x